Skip to main content
. 2023 May 12;10:1176710. doi: 10.3389/fcvm.2023.1176710

Table 3.

Overview of medical treatment for heart failure.

Prior index event (n) % After index event (n) %
B-Blockers 31 40,3 75 97,4
ACE-Inhibitors 18 23,4 19 24,7
AT-1 Receptor Blockers 15 19,5 8 10,4
Sacubitril/Valsartan 4 5,2 50 64,9
MRAs 12 15,6 65 84,4
SGLT2-Inhibitors 5 6,5 34 44,2

ACEs, angiotensin converting enzyme; AT-1, angiotensin-1; MRAs, mineralcorticoid receptor antagonists, SGLT2, sodium-glucose cotransporter-2.